C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD)

Archives of Gerontology and Geriatrics

Volumn 53, Issue 2, 2011, Pages 190-195

  Corsonello, Andrea ^a   Pedone, Claudio ^b,c   Battaglia, Salvatore ^d   Paglino, Giuseppe ^d   Bellia, Vincenzo ^d   Incalzi, Raffaele Antonelli ^b,e  

^a INRCA   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c Fondazione Alberto Sordi Onlus   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e Fondazione San Raffaele   (Italy)

Author keywords

C reactive protein; Chronic obstructive Pulmonary disease; Erythrocyte sedimentation rate

Indexed keywords

C REACTIVE PROTEIN;

AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FORCED EXPIRATORY VOLUME; GERIATRIC PATIENT; HUMAN; HYPOALBUMINEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL;

AGED; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 79960100654     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2010.10.015     Document Type: Article

References (47)

1. Aronson D., Roterman I., Yigla M., Kerner A., Avizohar O., Sella R., Bartha P., Levy Y., Markiewicz W. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am. J. Respir. Crit. Care Med. 2006, 174:626-632.
2. Broekhuizen R., Wouters E.F., Creutzberg E.C., Schols A.M. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006, 61:17-22.
3. Buess T., Ludwig C. Diagnostic value of C-reactive protein in comparison with erythrocyte sedimentation as routine admission diagnostic test. Schweiz. Med. Wochenschr. 1995, 125:120-124.
4. Buist A.S., Vollmer W.M., McBurnie M.A. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int. J. Tuberc. Lung Dis. 2008, 12:703-708.
5. Butland R.J., Pang J., Gross E.R., Woodcock A.A., Geddes D.M. Two-, six-,and 12-minute walking tests in respiratory disease. Br. Med. J. (Clin. Res. Ed.) 1982, 284:1607-1608.
6. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2004, 23:932-946.
7. Colglazier C.L., Sutej P.G. Laboratory testing in the rheumatic diseases: a practical review. South. Med. J. 2005, 98:185-191.
8. Crawford D.C., Sanders C.L., Qin X., Smith J.D., Shephard C., Wong M., Witrak L., Rieder M.J., Nickerson D.A. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 2006, 114:2458-2465.
9. Crawford J., Eye-Boland M.K., Cohen H.J. Clinical utility of erythrocyte sedimentation rate and plasma protein analysis in the elderly. Am. J. Med. 1987, 82:239-246.
10. Dahl M., Vestbo J., Lange P., Bojesen S.E., Tybjaerg-Hansen A., Nordestgaard B.G. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007, 175:250-255.
11. Dawson J.B. The ESR in a new dress. Br. Med. J. 1960, 1:1697-1704.
12. De Torres J.P., Cordoba-Lanus E., Lopez-Aguilar C., Muros de Fuentes M., Montejo de Garcini A., Aguirre-Jaime A., Celli B.R., Casanova C. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur. Respir. J. 2006, 27:902-907.
13. Denham E., Mohn B., Tucker L., Lun A., Cleave P., Boswell D.R. Evaluation of immunoturbidimetric specific protein methods using the Architect ci8200: comparison with immunonephelometry. Ann. Clin. Biochem. 2007, 44:529-536.
14. Eickhoff P., Valipour A., Kiss D., Schreder M., Cekici L., Geyer K., Kohansal R., Burghuber O.C. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008, 178:1211-1218.
15. Fletcher C.M., Elmes P.C., Fairbairn A.S., Wood C.H. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br. Med. J. 1959, 2:257-266.
16. Imafuku Y., Yoshida H., Greenfield S., Rabinovitch A. Automated measurement of erythrocyte sedimentation rate and its relation to red blood cell concentration and plasma proteins. Hematol. Cell. Ther. 1998, 40:27-32.
17. International Committee for Standardization in Haematology (expert panel on blood rheology) Guidelines on selection of laboratory tests for monitoring the acute phase response. J. Clin. Pathol. 1988, 41:1203-1212.
18. Jiang R., Burke G.L., Enright P.L., Newman A.B., Margolis H.G., Cushman M., Tracy R.P., Wang Y., Kronmal R.A., Barr R.G. Inflammatory markers and longitudinal lung function decline in the elderly. Am. J. Epidemiol. 2008, 168:602-610.
19. John M., Hoernig S., Doehner W., Okonko D.D., Witt C., Anker S.D. Anemia and inflammation in COPD. Chest 2005, 127:825-829.
20. Karadag F., Kirdar S., Karul A.B., Ceylan E. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur. J. Intern. Med. 2008, 19:104-108.
21. Kimberly M.M., Vesper H.W., Caudill S.P., Cooper G.R., Rifai N., Dati F., Myers G.L. Standardization of immunoassays for measurement of high-sensitivity C-reactive protein. Phase I: evaluation of secondary reference materials. Clin. Chem. 2003, 49:611-616.
22. Kimberly M.M., Caudill S.P., Vesper H.W., Monsell E.A., Miller W.G., Rej R., Rifai N., Dati F., Myers G.L. Standardization of high-sensitivity immunoassays for measurement of C-reactive protein. II. Two approaches for assessing commutability of a reference material. Clin. Chem. 2009, 55:342-350.
23. Kirdar S., Serter M., Ceylan E., Sener A.G., Kavak T., Karadag F. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Scand. J. Clin. Lab. Invest. 2009, 69:219-224.
24. Ko F.W., Hui D.S., Lai C.K. Worldwide burden of COPD in high- and low-income countries. Part III. Asia-Pacific studies. Int. J. Tuberc. Lung Dis. 2008, 12:713-717.
25. Mahoney F.I., Barthel D.W. Functional evaluation: the Barthel index. Md. State Med. J. 1965, 14:61-65.
26. Man S.F., Connett J.E., Anthonisen N.R., Wise R.A., Tashkin D.P., Sin D.D. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006, 61:849-853.
27. Melbye H., Halvorsen D.S., Hartz I., Medbo A., Brox J., Eggen A.E., Njølstad I. Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. The Tromso Study 2001. Respir. Med. 2007, 101:2541-2549.
28. Menezes A.M., Perez-Padilla R., Hallal P.C., Jardim J.R., Muino A., Lopez M.V., Valdivia G., Pertuze J., Montes de Oca M., Tálamo C. Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study. Int. J. Tuberc. Lung Dis. 2008, 12:709-712.
29. Osei-Bimpong A., Meek J.H., Lewis S.M. ESR or CRP? A comparison of their clinical utility. Hematology 2007, 12:353-357.
30. Packard R.R., Libby P. Inflammation in atherosclerosis: from vascular bio-logy to biomarker discovery and risk prediction. Clin. Chem. 2008, 54:24-38.
31. Poulain M., Doucet M., Drapeau V., Fournier G., Tremblay A., Poirier P., Maltais F. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chron. Respir. Dis. 2008, 5:35-41.
32. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., Fukuchi Y., Jenkins C., Rodriguez-Roisin R., van Weel C., Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007, 176:532-555.
33. Reinhart W.H. Erythrocyte sedimentation rate-more than an old fashion?. Ther. Umsch. 2006, 63:108-112.
34. Rufer A., Criblez D., Wuillemin W.A. Iron-deficiency anemia and gastro-intestinal bleeding. Ther. Umsch. 2006, 63:339-343.
35. Shorr A., Doyle J., Stern L., Dolgitser M., Zilberberg M.D. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr. Med. Res. Opin. 2008, 24:1123-1130.
36. Sin D.D., Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003, 107:1514-1519.
37. Sin D.D., Leung R., Gan W.Q., Man S.P. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm. Med. 2007, 7:13.
38. Szekanecz Z., Koch A.E. Vascular involvement in rheumatic diseases: 'vascular rheumatology'. Arthritis Res. Ther. 2008, 10:224.
39. Takabatake N., Nakamura H., Abe S., Inoue S., Hino T., Saito H., Yuki H., Kato S., Tomoike H. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000, 161:1179-1184.
40. Tkacova R., Kluchova Z., Joppa P., Petrasova D., Molcanyiova A. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD. Respir. Med. 2007, 101:1670-1676.
41. Valipour A., Schreder M., Wolzt M., Saliba S., Kapiotis S., Eickhoff P., Burghuber O.C. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Clin. Sci. (Lond.) 2008, 115:225-232.
42. Vellas B., Guigoz Y., Garry P.J., Nourhashemi F., Bennahum D., Lauque S., Albarede J.L. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999, 15:116-122.
43. Ward M.M. Clinical measures in rheumatoid arthritis: which are most useful in assessing patients?. J. Rheumatol. 1994, 21:17-27.
44. Wetteland P., Roger M., Solberg H.E., Iversen O.H. Population-based erythrocyte sedimentation rates in 3910 subjectively healthy Norwegian adults. A statistical study based on men and women from the Oslo area. J. Intern. Med. 1996, 240:125-131.
45. Wilson P.W. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective. Am. J. Med. 2008, 121(Suppl. 1):S15-S20.
46. Yanbaeva D.G., Dentener M.A., Creutzberg E.C., Wesseling G., Wouters E.F. Systemic effects of smoking. Chest 2007, 131:1557-1566.
47. Zlonis M. The mystique of the erythrocyte sedimentation rate. A reappraisal of one of the oldest laboratory tests still in use. Clin. Lab. Med. 1993, 13:787-800.